EDWARDS LIFESCIENCES STARR-EDWARDS SILASTIC BALL HEART VALVE PROSTHESIS; HEART-VALVE, MECHANICAL
|
Back to Search Results |
|
Model Number 6120 |
Device Problems
Gradient Increase (1270); Patient Device Interaction Problem (4001)
|
Patient Problems
Atrial Flutter (1730); Dyspnea (1816); Heart Failure/Congestive Heart Failure (4446)
|
Event Date 11/01/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
The date of event is unknown; however, the date when the article was received for publication (1 nov 2021) was used as the occurrence date.The device was not returned for evaluation, as the device request is ongoing.Article citation: rahmouni k, naidu j, pearce n, chan v.Successful explantation of a ball and cage mitral valve prosthesis 48 years after initial implantation.Cjc open.2021 nov 21;4(3):344-346.Doi: 10.1016/j.Cjco.2021.11.007.Pmid: 35386136; pmcid: pmc8978051.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
Event Description
|
Through review of medical article " successful explantation of a ball and cage mitral valve prosthesis 48 years after initial implantation" , the following event was identified as pertaining to an edwards device: this 58-year-old patient underwent explantation of a starr-edwards ball and cage prosthesis from the mitral position after an implant duration of forty-eight (48) years.Patient developed nyha class iv dyspnea refractory to medical therapy and experienced chronic atrial flutter.Transthoracic echocardiography (tee) confirmed severe mitral stenosis with a mean gradient of 17 mm hg and a peak gradient of 35 mm hg.Intraoperatively, the prosthesis was covered in dense calcified pannus.A non-edwards mechanical valve was implanted in replacement.Patient remained well, without functional limitations, ten (10) months after the surgery.
|
|
Manufacturer Narrative
|
The serial number was not provided.Therefore, the device history record (dhr) could not be reviewed.The growth of host tissue on the sewing ring is expected and is a natural part of the healing reaction to prosthesis implantation.A small amount of host tissue growth over the suture line is needed to form a non-thrombogenic surface and complete the healing process after valve implantation.In contrast, if there is an excessive amount of pannus growth, it can lead to restricted mobility, elevated gradients, and stenosis.Host fibrous (pannus) tissue growth is not a malfunction of the device.The most likely cause is patient factors.
|
|
Search Alerts/Recalls
|
|
|